Status:
RECRUITING
Longitudinal Study for Relapsing Polychondritis
Lead Sponsor:
University of Pennsylvania
Conditions:
Relapsing Polychondritis
Vasculitis
Eligibility:
All Genders
Brief Summary
Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less comm...
Detailed Description
Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less comm...
Eligibility Criteria
Inclusion
- 1\. Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.
Exclusion
- 1\. Inability to provide consent, or in the case of minors, assent.
Key Trial Info
Start Date :
February 26 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04919538
Start Date
February 26 2021
End Date
January 1 2026
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104